News of the WeekSTEM CELL RESEARCH

Harvard Cloners Get OK to Proceed With Caution

See allHide authors and affiliations

Science  16 Jun 2006:
Vol. 312, Issue 5780, pp. 1584
DOI: 10.1126/science.312.5780.1584b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Harvard University researchers last week were given the go-ahead to use cloning to create disease-specific lines of human embryonic stem cells, making Harvard the second U.S. academic institution to use research cloning as a tool for studying diseases such as diabetes and Parkinson's. (Read more.)